ONIRIA Therapeutics Archives

Oniria Therapeutics, VHIO and ICIQ awarded over €1.7 million from Spanish Ministry of Science and Innovation to advance ONR-001 drug targeting resistant colon cancer

Biopharmaceutical company Oniria Therapeutics, Vall d’Hebron Institute of Oncology (VHIO) and Institut Català d’Investigació Química (ICIQ) will work together on…